Novartis Investigator Site

Alicante

0 studies enrolling now · 8 studies all time

What they study most

Asthma, COPD, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive, Rheumatoid Arthritis

Studies at this site

• Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis — Completed
• Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma — Completed
• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease — Completed